Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1300030	重组抗CD20人鼠嵌合单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2013-05-13	山东新时代药业有限公司	Shandong New Time Pharmaceutical Co Ltd	Certificate Issued	2016-05-31	view
CXSL1500074	重组抗CD20人鼠嵌合单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2015-09-21	南京优科生物医药有限公司	Nanjing YOKO Pharmaceutical Co Ltd	Certificate Issued	2016-09-04	view
CXSL2101050	重组抗CD20人鼠嵌合单克隆抗体注射液	rituximab	Injection	Biological Products(3.3)	New Drug Application	2021-04-30		Shandong New Time Pharmaceutical Co Ltd			view
CXSS1100021	重组抗CD20人鼠嵌合单克隆抗体注射液	rituximab	Injection	Biological Products(2)	New Drug Application	2012-01-29	上海中信国健药业股份有限公司	Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd	Certificate Issued	2016-11-09	view